This NDC is on FDA's drug shortage list (posted Oct 31, 2017)

Product Information

HYDROMORPHONE 500 MG/50 ML VIAL is a generic product labeled by Hospira Inc., priced at $2.5663 per ML under NDC 00409263450. Its NADAC has been published 36 times since Jan 22, 2014.

FDA first approved this application on Jun 17, 2008. Its Orange Book therapeutic-equivalence code is AP.

HYDROMORPHONE 500 MG/50 ML VIAL

Hydromorphone Hydrochloride
$2.5663per ML
DEA Schedule CII

Strength

10 mg/mL

Manufacturer

Hospira Inc.

NDC

00409263450

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS

Effective Date

5/20/2026

Active Ingredients

HYDROMORPHONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA078591

FDA Approved

6/17/2008

TE Code

AP

On Market Since

7/31/2008

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for HYDROMORPHONE 500 MG/50 ML VIAL has been published 36 times since Jan 22, 2014, and over the history we have for it it has risen 40.6%. The table below summarizes its recorded NADAC range and movement.

Current price$2.5663 per ML
All-time high$2.5663 (Aug 19, 2026)
All-time low$1.8255 (Jan 22, 2014)
52-week high$2.5663
52-week low$2.4402
Median price$2.5453
Average price$2.4365
Largest weekly change+33.7% (Jan 21, 2026)
Weeks tracked36
Tracking sinceJan 22, 2014

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+2.5%

1Y

+40.6%

3Y

+40.6%

5Y

+40.6%

All

+40.6%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of HYDROMORPHONE 500 MG/50 ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for HYDROMORPHONE 500 MG/50 ML VIAL, manufactured by Hospira Inc., is $2.5663 per ML (NDC 00409263450), effective Aug 19, 2026.

How has the price of HYDROMORPHONE 500 MG/50 ML VIAL changed over time?

Over the history we have for it, the NADAC for HYDROMORPHONE 500 MG/50 ML VIAL has risen 40.6%. It has been tracked across 36 weekly CMS publications since Jan 22, 2014.

What are the highest and lowest recorded NADAC prices for HYDROMORPHONE 500 MG/50 ML VIAL?

Since Jan 22, 2014, the NADAC for HYDROMORPHONE 500 MG/50 ML VIAL has ranged from a low of $1.8255 (Jan 22, 2014) to a high of $2.5663 (Aug 19, 2026), with a median of $2.5453 per ML.

Are there cheaper alternatives to HYDROMORPHONE 500 MG/50 ML VIAL?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as HYDROMORPHONE 500 MG/50 ML VIAL in a comparable dosage form, but none are currently priced below it.

Who manufactures HYDROMORPHONE 500 MG/50 ML VIAL?

HYDROMORPHONE 500 MG/50 ML VIAL (NDC 00409263450) is labeled by Hospira Inc., and CMS classifies it as a generic product.

Is HYDROMORPHONE 500 MG/50 ML VIAL in shortage?

Yes — NDC 00409263450 is currently listed in FDA's drug shortage database (posted Oct 31, 2017).